Balaban, R. Et Al. 2023. Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells. Cellular Bases for Patient Response to Cancer Therapies , (Lyon, France), 3.

Balaban, R., Çeçener, G., Patır, İ., Şahin, S., Haliç Poslu, A., Koz, G., ... Huriyet, N.(2023). Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells . Cellular Bases for Patient Response to Cancer Therapies (pp.3). Lyon, France

Balaban, Rumeysa Et Al. "Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells," Cellular Bases for Patient Response to Cancer Therapies, Lyon, France, 2023

Balaban, Rumeysa Et Al. "Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells." Cellular Bases for Patient Response to Cancer Therapies , Lyon, France, pp.3, 2023

Balaban, R. Et Al. (2023) . "Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells." Cellular Bases for Patient Response to Cancer Therapies , Lyon, France, p.3.

@conferencepaper{conferencepaper, author={Rumeysa Balaban Et Al. }, title={Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells}, congress name={Cellular Bases for Patient Response to Cancer Therapies}, city={Lyon}, country={France}, year={2023}, pages={3} }